Pharma IQ Members

Lada
Laenen

In 2008 and 2009, Genzyme sites were affected by vesivirus infection. This shutdown two sites for decontamination. In this candid interview, Lada Laenen, Managing Principal Scientist, Head, Cell Culture and Microbiology, Genzyme, a Sanofi Company, speaks to Pharma IQ of how this affected the company and what they learned. She also describes how...Full Article »